» Articles » PMID: 15199152

Distinct Mechanisms for Repression of RNA Polymerase III Transcription by the Retinoblastoma Tumor Suppressor Protein

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2004 Jun 17
PMID 15199152
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

The retinoblastoma (RB) protein represses global RNA polymerase III transcription of genes that encode nontranslated RNAs, potentially to control cell growth. However, RNA polymerase III-transcribed genes exhibit diverse promoter structures and factor requirements for transcription, and a universal mechanism explaining global repression is uncertain. We show that RB represses different classes of RNA polymerase III-transcribed genes via distinct mechanisms. Repression of human U6 snRNA (class 3) gene transcription occurs through stable promoter occupancy by RB, whereas repression of adenovirus VAI (class 2) gene transcription occurs in the absence of detectable RB-promoter association. Endogenous RB binds to a human U6 snRNA gene in both normal and cancer cells that maintain functional RB but not in HeLa cells whose RB function is disrupted by the papillomavirus E7 protein. Both U6 promoter association and transcriptional repression require the A/B pocket domain and C region of RB. These regions of RB contribute to U6 promoter targeting through numerous interactions with components of the U6 general transcription machinery, including SNAP(C) and TFIIIB. Importantly, RB also concurrently occupies a U6 promoter with RNA polymerase III during repression. These observations suggest a novel mechanism for RB function wherein RB can repress U6 transcription at critical steps subsequent to RNA polymerase III recruitment.

Citing Articles

Adenovirus small E1A directs activation of Alu transcription at YAP/TEAD- and AP-1-bound enhancers through interactions with the EP400 chromatin remodeler.

Cantarella S, Vezzoli M, Carnevali D, Morselli M, Zemke N, Montanini B Nucleic Acids Res. 2024; 52(16):9481-9500.

PMID: 39011896 PMC: 11381368. DOI: 10.1093/nar/gkae615.


Selective Occupation by E2F and RB of Loci Expressed by RNA Polymerase III.

Sizer R, Butterfield S, Hancocks L, Gato De Sousa L, White R Cancers (Basel). 2024; 16(3).

PMID: 38339234 PMC: 10854548. DOI: 10.3390/cancers16030481.


Targeting BRF2 in Cancer Using Repurposed Drugs.

Rashidieh B, Molakarimi M, Mohseni A, Tria S, Truong H, Srihari S Cancers (Basel). 2021; 13(15).

PMID: 34359683 PMC: 8345145. DOI: 10.3390/cancers13153778.


RNF12 catalyzes BRF1 ubiquitination and regulates RNA polymerase III-dependent transcription.

Wang F, Zhao K, Yu S, Xu A, Han W, Mei Y J Biol Chem. 2018; 294(1):130-141.

PMID: 30413534 PMC: 6322886. DOI: 10.1074/jbc.RA118.004524.


Abnormal expression of TFIIIB subunits and RNA Pol III genes is associated with hepatocellular carcinoma.

Lei J, Chen S, Zhong S Liver Res. 2017; 1(2):112-120.

PMID: 29276645 PMC: 5739085. DOI: 10.1016/j.livres.2017.08.005.


References
1.
Harbour J, Dean D . The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev. 2000; 14(19):2393-409. DOI: 10.1101/gad.813200. View

2.
Takahashi Y, Rayman J, Dynlacht B . Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. Genes Dev. 2000; 14(7):804-16. PMC: 316494. View

3.
HIRSCH H, Gu L, Henry R . The retinoblastoma tumor suppressor protein targets distinct general transcription factors to regulate RNA polymerase III gene expression. Mol Cell Biol. 2000; 20(24):9182-91. PMC: 102176. DOI: 10.1128/MCB.20.24.9182-9191.2000. View

4.
Sutcliffe J, Brown T, Allison S, Scott P, White R . Retinoblastoma protein disrupts interactions required for RNA polymerase III transcription. Mol Cell Biol. 2000; 20(24):9192-202. PMC: 102177. DOI: 10.1128/MCB.20.24.9192-9202.2000. View

5.
Nielsen S, Schneider R, Bauer U, Bannister A, Morrison A, OCarroll D . Rb targets histone H3 methylation and HP1 to promoters. Nature. 2001; 412(6846):561-5. DOI: 10.1038/35087620. View